SIRT1 and metabolic dysfunction-associated steatohepatitis: Furthermore, miR-34a, which directly targets sirtuin 1 (SIRT1), were inhibited by ursodeoxycholic acid (UDCA) in the rat liver and activated by disease severity in human NASH (18).